Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/12—Nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings

Application Number	Priority Date	Filing Date	Title
US19654900P	2000-04-11	2000-04-11
US50196549		2000-04-11
PCT/US2001/011714WO2001077086A1 (en)	2000-04-11	2001-04-11	SUBSTITUTED LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION

Publication Number	Publication Date
AU2001257006A1true AU2001257006A1 (en)	2001-10-23

Family

ID=22725848

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001257006AAbandonedAU2001257006A1 (en)	2000-04-11	2001-04-11	Substituted lactams as inhibitors of abeta protein production

Country Status (6)

Country	Link
US (7)	US6632812B2 (en)
EP (1)	EP1289966A1 (en)
JP (1)	JP2004500419A (en)
AU (1)	AU2001257006A1 (en)
CA (1)	CA2404273A1 (en)
WO (1)	WO2001077086A1 (en)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001257006A1 (en)*	2000-04-11	2001-10-23	Du Pont Pharmaceuticals Company	Substituted lactams as inhibitors of abeta protein production
US20100009966A1 (en)*	2001-04-11	2010-01-14	Bristol-Myers Squibb Pharma Company	Substituted lactams as inhibitors of abeta protein production
US7146209B2 (en)*	2000-05-08	2006-12-05	Brainsgate, Ltd.	Stimulation for treating eye pathologies
US7640062B2 (en)	2000-05-08	2009-12-29	Brainsgate Ltd.	Methods and systems for management of alzheimer's disease
AU2001261728A1 (en)	2000-05-17	2001-11-26	Bristol-Myers Squibb Pharma Company	Use of small molecule radioligands for diagnostic imaging
GB0012671D0 (en)*	2000-05-24	2000-07-19	Merck Sharp & Dohme	Therapeutic agents
EP1469810A4 (en)	2002-01-04	2009-01-14	Univ Rockefeller	COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF DISEASES RELATED TO AMYLOID-BETA PEPTIDE
US7684859B2 (en)*	2002-04-25	2010-03-23	Brainsgate Ltd.	Stimulation of the OTIC ganglion for treating medical conditions
JP2006500318A (en)*	2002-04-25	2006-01-05	ブレインスゲートリミテッド	Method and apparatus for adjusting the characteristics of BBB and cerebral circulation using nerve excitatory and / or neurosuppressive effects of odorants on the intracranial nerve
US7001901B2 (en)	2002-08-27	2006-02-21	Bristol-Myers Squibb Company	Tetrazolylpropionamides as inhibitors of Aβ protein production
EP1585430B1 (en)*	2002-11-14	2017-01-11	Brainsgate Ltd.	Surgical tools and techniques for stimulation
MXPA05008172A (en)	2003-02-04	2005-10-05	Hoffmann La Roche	Malonamide derivatives as gamma-secretase inhibitors.
US7475413B2 (en)*	2003-07-31	2009-01-06	Inphase Technologies, Inc.	Data storage cartridge having a reduced thickness segment
EP1711470B1 (en)*	2003-09-09	2009-04-15	F. Hoffmann-La Roche Ag	Malonamide derivatives blocking the activtiy of gamma-secretase
BRPI0415070B8 (en)*	2003-10-06	2021-05-25	Hoffmann La Roche	useful substituted dibenzo-azepine and substituted benzo-diazepine derivatives, their use and preparation process, and medicine
US7763609B2 (en)	2003-12-15	2010-07-27	Schering Corporation	Heterocyclic aspartyl protease inhibitors
US8010189B2 (en)*	2004-02-20	2011-08-30	Brainsgate Ltd.	SPG stimulation for treating complications of subarachnoid hemorrhage
US8055347B2 (en)	2005-08-19	2011-11-08	Brainsgate Ltd.	Stimulation for treating brain events and other conditions
US9233245B2 (en)	2004-02-20	2016-01-12	Brainsgate Ltd.	SPG stimulation
WO2006021957A2 (en)*	2004-08-23	2006-03-02	Brainsgate Ltd.	Concurrent bilateral spg modulation
ES2398531T3 (en)*	2006-03-27	2013-03-20	F. Hoffmann-La Roche Ag	Malonamide derivatives as gamma secretase inhibitors
US20090210026A1 (en)*	2006-08-17	2009-08-20	Brainsgate Ltd.	Spg stimulation for enhancing neurogenesis and brain metabolism
WO2008079909A1 (en)*	2006-12-21	2008-07-03	Plexxikon, Inc.	Pyrrolo [2,3-b] pyridines as kinase modulators
CA2676160A1 (en)	2007-02-02	2008-08-07	F. Hoffmann-La Roche Ag	6-oxo-6,7-dihydro-5h-dibenzo[b,d]azepin-7-yl derivatives
US20100204230A1 (en)	2007-02-12	2010-08-12	Peter Blurton	Piperazine derivatives for treatment of ad and related conditions
EP2146722A4 (en)*	2007-05-10	2011-08-03	Amr Technology Inc	Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
US7860569B2 (en)	2007-10-18	2010-12-28	Brainsgate, Ltd.	Long-term SPG stimulation therapy for prevention of vascular dementia
CN101945853B (en)	2007-12-21	2014-08-20	配体药物公司	Selective androgen receptor modulators (sarms) and uses thereof
EP2291181B9 (en)	2008-04-18	2013-09-11	University College Dublin National University Of Ireland, Dublin	Captodiamine for the treatment of depression symptoms
EP3586839A1 (en)	2008-07-28	2020-01-01	Blanchette Rockefeller Neurosciences, Institute	Pkc-activating compounds for the treatment of neurodegenerative diseases
US9023767B2 (en)*	2009-05-07	2015-05-05	Memorial Sloan-Kettering Cancer Center	γ-Secretase substrates and methods of use
SG10201507362TA (en)	2009-08-05	2015-10-29	Intra Cellular Therapies Inc	Novel Regulatory Proteins And Inhibitors
WO2012033831A2 (en)	2010-09-07	2012-03-15	Memorial Sloan-Kettering Cancer Center	Methods and compositions for gamma-secretase assay
TWI530489B (en)	2011-03-22	2016-04-21	必治妥美雅史谷比公司	Bis(fluoroalkyl)-1,4-benzodiazepine compound
US9242941B2 (en)	2012-09-21	2016-01-26	Bristol-Myers Squibb Company	Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds
EP2897944B1 (en)	2012-09-21	2016-10-26	Bristol-Myers Squibb Company	Substituted 1,5-benzodiazepinone compounds
JP2015529250A (en)	2012-09-21	2015-10-05	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	Fluoroalkyldibenzodiazepinone compounds
JP2015529251A (en)	2012-09-21	2015-10-05	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	Tricyclic heterocyclic compounds as NOTCH inhibitors
US9427442B2 (en)	2012-09-21	2016-08-30	Bristol-Myers Squibb Company	Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds
WO2014047392A1 (en)	2012-09-21	2014-03-27	Bristol-Myers Squibb Company	Fluoroalkyl-1,4-benzodiazepinone compounds
JP2015531792A (en)	2012-09-21	2015-11-05	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	Prodrugs of 1,4-benzodiazepinone compounds
TWI614238B (en)	2012-09-21	2018-02-11	必治妥美雅史谷比公司	Bis(fluoroalkyl)-1,4-benzodiazepine compounds and prodrugs thereof
US9242940B2 (en)	2012-09-21	2016-01-26	Bristol-Myers Squibb Company	N-substituted bis(fluoroalkyl)-1,4-benzodiazepinone compounds
EP2981267A1 (en)	2013-04-04	2016-02-10	Bristol-Myers Squibb Company	Combination therapy for the treatment of proliferative diseases
US9675796B2 (en)	2013-11-10	2017-06-13	Brainsgate Ltd.	Implant and delivery system for neural stimulator
US10441567B2 (en)	2014-01-17	2019-10-15	Ligand Pharmaceuticals Incorporated	Methods and compositions for modulating hormone levels
US10271907B2 (en)	2015-05-13	2019-04-30	Brainsgate Ltd.	Implant and delivery system for neural stimulator
JP2022529341A (en)	2019-04-19	2022-06-21	リガンド・ファーマシューティカルズ・インコーポレイテッド	The crystalline form of the compound and the method for producing the crystalline form of the compound.
CN111592459B (en)*	2020-06-28	2021-10-15	北京博萃循环科技有限公司	Carboxylic acid compound, its preparation method and application

Family Cites Families (92)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2934355A1 (en)	1979-08-24	1981-03-12	Bayer Ag, 5090 Leverkusen	Antibacterial alpha-amino-lactam urethane and thio:urethane derivs. - prepd. e.g. by reaction of an alpha-amino-lactam with a carbonic or thiocarbonic acid ester halide
US4666829A (en)*	1985-05-15	1987-05-19	University Of California	Polypeptide marker for Alzheimer's disease and its use for diagnosis
EP0411668B2 (en)	1989-08-04	1998-11-11	MERCK SHARP & DOHME LTD.	Central cholecystokinin antagonists for treatment of psychiatric disorders
CA2026856A1 (en)	1989-10-05	1991-04-06	Mark G. Bock	3-substituted-1,4-benzodiazepines useful as oxytocin
CA2032427A1 (en)	1989-12-18	1991-06-19	Mark G. Bock	Benzodiazepines analogs
US5576829A (en)*	1990-10-08	1996-11-19	Nikon Corporation	Method and apparatus for inspecting a phase-shifted mask
US5206235A (en)*	1991-03-20	1993-04-27	Merck & Co., Inc.	Benzo-fused lactams that promote the release of growth hormone
US5389631A (en)	1991-10-29	1995-02-14	Merck & Co., Inc.	Fibrinogen receptor antagonists
US5766846A (en)*	1992-07-10	1998-06-16	Athena Neurosciences	Methods of screening for compounds which inhibit soluble β-amyloid peptide production
JP3457312B2 (en)	1992-07-29	2003-10-14	メルクシヤープエンドドームリミテツド	Benzodiasepine derivative
US5283241A (en)	1992-08-28	1994-02-01	Merck & Co., Inc.	Benzo-fused lactams promote release of growth hormone
US5872596A (en)*	1992-09-28	1999-02-16	Canon Kabushiki Kaisha	Device for widening the dynamic range of solid-state image pickup elements
US5389831A (en)*	1992-12-17	1995-02-14	Vlsi Technology, Inc.	Clock generator for providing a pair of nonoverlapping clock signals with adjustable skew
CN1041921C (en)	1992-12-21	1999-02-03	史密丝克莱恩比彻姆公司	bicyclic fibrinogen antagonist
MX9308016A (en)	1992-12-22	1994-08-31	Lilly Co Eli	HUMAN IMMUNODEFICIENCY VIRUS PROTEASE INHIBITING COMPOUNDS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL FORMULATION CONTAINING THEM.
CA2160786A1 (en)	1993-05-14	1994-11-24	James C. Marsters, Jr.	Ras farnesyl transferase inhibitors
AU7102394A (en)	1993-06-09	1995-01-03	Smithkline Beecham Corporation	Bicyclic fibrinogen antagonists
IL110525A0 (en)	1993-08-09	1994-11-11	Lilly Co Eli	Identification and use of protease inhibitors
US5691339A (en)*	1993-08-25	1997-11-25	The Green Cross Corporation	Circulatory disorder improving agent
US5545735A (en)	1993-10-04	1996-08-13	Merck & Co., Inc.	Benzo-Fused Lactams promote release of growth hormone
US5426185A (en)	1993-11-22	1995-06-20	Merck & Co., Inc.	Antiarrhythmic benzodiazepines
FR2716509B1 (en)*	1994-01-19	1996-04-12	Alliedsignal Automotive Espana	Disc brake with increased safety.
US5514716A (en)	1994-02-25	1996-05-07	Sterling Winthrop, Inc.	Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
US5716929A (en)*	1994-06-17	1998-02-10	Vertex Pharmaceuticals, Inc.	Inhibitors of interleukin-1β converting enzyme
CA2196062A1 (en)	1994-07-29	1996-02-15	Yoshinari Sato	Benzodiazepine derivatives
EP0776203A4 (en)*	1994-08-18	1997-12-29	Merck & Co Inc	N-2,3-dihydro-1-(2-propyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines
US5550128A (en)*	1994-09-09	1996-08-27	Nair; Madhavan G.	Enantiomers of gamma methylene 10-deaza aminopterin and process for preparing the same
US5661161A (en)	1994-09-29	1997-08-26	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
JPH11505509A (en)	1994-12-09	1999-05-21	スミスクライン・ビーチャム・コーポレイション	Bicyclic fibrinogen antagonist
US5639746A (en)	1994-12-29	1997-06-17	The Procter & Gamble Company	Hydroxamic acid-containing inhibitors of matrix metalloproteases
WO1996018602A1 (en)	1994-12-13	1996-06-20	Smithkline Beecham Corporation	Bicyclic fibrinogen antagonists
DE19500040A1 (en)	1995-01-03	1996-07-04	Basf Ag	Process for the preparation of aliphatic alpha, omega-aminonitriles in the gas phase
KR100394930B1 (en)*	1995-02-07	2003-12-18	비큐론 파마세티컬스 인코포레이티드	Basic Oxazoline-Amide Derivatives of GE 2270 and GE 2270-like Antibiotics
US5672598A (en)	1995-03-21	1997-09-30	The Procter & Gamble Company	Lactam-containing hydroxamic acids
US5578629A (en)	1995-03-29	1996-11-26	Merck & Co., Inc.	Benzamide-containing inhibitors of farnesyl-protein transferase
US5856326A (en)	1995-03-29	1999-01-05	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
GB9507799D0 (en)	1995-04-18	1995-05-31	British Biotech Pharm	Metalloproteinase inhibitors
US5673437A (en)*	1995-05-08	1997-10-07	Chase Ergonomics Inc.	Vibration attenuating member and method of making same
US5710171A (en)	1995-05-24	1998-01-20	Merck & Co., Inc.	Bisphenyl inhibitors of farnesyl-protein transferase
EP0828754B1 (en)	1995-05-29	2005-02-02	Pfizer Inc.	Dipeptides which promote release of growth hormone
US5756528A (en)	1995-06-06	1998-05-26	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
US5691331A (en)*	1995-06-07	1997-11-25	Merck & Co., Inc.	N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides
US5726171A (en)*	1995-06-07	1998-03-10	Merck & Co Inc	N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo B! 1,4!diazepin-3yl)-acetamides
EP0761680A3 (en)	1995-09-12	1999-05-06	Ono Pharmaceutical Co., Ltd.	Tetrazole compounds having Interleukin-1beta converting enzyme inhibitory activity
WO1997019053A1 (en)	1995-11-23	1997-05-29	British Biotech Pharmaceuticals Limited	Metalloproteinase inhibitors
JP2000504014A (en)	1996-01-30	2000-04-04	メルクエンドカンパニーインコーポレーテッド	Farnesyl-protein transferase inhibitor
US5852010A (en)	1996-04-03	1998-12-22	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
AU715603B2 (en)	1996-04-03	2000-02-03	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
CA2250460A1 (en)	1996-04-03	1997-10-09	John H. Hutchinson	Inhibitors of farnesyl-protein transferase
US5965578A (en)	1996-04-03	1999-10-12	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
US5885995A (en)	1996-04-03	1999-03-23	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
US5919785A (en)	1996-04-03	1999-07-06	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
US5891889A (en)	1996-04-03	1999-04-06	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
AU2555997A (en)	1996-04-03	1997-10-22	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
US5869682A (en)	1996-04-03	1999-02-09	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
US5859012A (en)	1996-04-03	1999-01-12	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
CA2251955A1 (en)	1996-04-18	1997-10-23	Nancy E. Kohl	A method of treating cancer
EP0934270A1 (en)	1996-05-30	1999-08-11	Merck & Co., Inc.	A method of treating cancer
US5703129A (en)*	1996-09-30	1997-12-30	Bristol-Myers Squibb Company	5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of β-amyloid protein production
JP2001504810A (en)	1996-10-11	2001-04-10	シーオーアール・セラピューティックス・インコーポレーテッド	Selective factor Xa inhibitor
PL323130A1 (en)	1996-11-15	1998-05-25	Hoechst Ag	Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such
IL129238A0 (en)	1996-11-22	2000-02-17	Elan Pharm Inc	N-(aryl/heteroarylacetyl) amino acid esters pharmaceutical compositions comprising same and methods for inhibiting b-amyloid peptide release and/ or its synthesis by use of such compounds
ATE296797T1 (en)	1996-11-22	2005-06-15	Elan Pharm Inc	N-(ARYL/HETEROARYL/ALKYLACETYL) AMINO ACID AMIDES, PHARMACEUTICAL COMPOSITIONS THEREFOR, AND METHODS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE OR SYNTHESIS
NZ335157A (en)	1996-11-22	2001-01-26	Elan Pharm Inc	N-(aryl/heteroaryl) amino acid derivatives and methods for inhibiting beta-amyloid peptide release or its synthesis
AU5585198A (en)	1996-11-22	1998-06-10	Athena Pharmaceuticals, Inc.	N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and ethods for inhibiting beta-amyloid peptide release and/or its synthesis
TW523506B (en)	1996-12-18	2003-03-11	Ono Pharmaceutical Co	Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
EA002100B1 (en)	1996-12-23	2001-12-24	Элан Фармасьютикалз, Инк.	CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHOD FOR INHIBITING beta-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESISBY USE OF SUCH COMPOUNDS
CA2276081A1 (en)	1996-12-30	1998-07-09	Lekhanh O. Tran	Inhibitors of farnesyl-protein transferase
JP2002241368A (en)*	1997-02-18	2002-08-28	Shionogi & Co Ltd	New benzolactam derivative and pharmaceutical composition containing the same
EP0968206B8 (en)	1997-02-19	2007-01-24	Berlex, Inc.	N-heterocyclic derivatives as nos inhibitors
WO1998041510A1 (en)	1997-03-14	1998-09-24	Shionogi & Co., Ltd.	Novel benzolactam derivatives and medicinal compositions comprising the same
US5817658A (en)*	1997-03-14	1998-10-06	Merck & Company, Inc.	Method for treating Meniere's disease
EP0973396A4 (en)	1997-04-07	2001-02-07	Merck & Co Inc	A method of treating cancer
US6060038A (en)	1997-05-15	2000-05-09	Merck & Co., Inc.	Radiolabeled farnesyl-protein transferase inhibitors
DE19726427A1 (en)	1997-06-23	1998-12-24	Boehringer Mannheim Gmbh	Pyrimidine-2,4,6-trione derivatives, processes for their preparation and medicaments containing these compounds
GB9715030D0 (en)	1997-07-18	1997-09-24	British Biotech Pharm	Metalloproteinase inhibitors
ATE211482T1 (en)	1997-08-11	2002-01-15	Cor Therapeutics Inc	SELECTIVE INHIBITORS OF FACTOR X CONTAINING AN AZEPINE STRUCTURE
JP2001515842A (en)	1997-08-11	2001-09-25	シーオーアールセラピューティクスインコーポレイテッド	Selective factor Xa inhibitor
AU735366B2 (en)	1997-09-29	2001-07-05	Bristol-Myers Squibb Company	Inhibitors of farnesyl protein transferase
US6297239B1 (en)	1997-10-08	2001-10-02	Merck & Co., Inc.	Inhibitors of prenyl-protein transferase
US6440965B1 (en)	1997-10-15	2002-08-27	Krenitsky Pharmaceuticals, Inc.	Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
AU1277799A (en)*	1997-12-22	1999-07-12	Elan Pharmaceuticals, Inc.	Polycyclic alpha-amino-$m(e)-caprolactams and related compounds
CA2324475A1 (en)	1998-06-22	1999-12-29	Elan Pharmaceuticals, Inc.	Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
AU5204799A (en)	1998-06-22	2000-01-10	Elan Pharmaceuticals, Inc.	Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
US6552013B1 (en)*	1998-06-22	2003-04-22	Elan Pharmaceuticals, Inc.	Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
WO1999067221A1 (en)	1998-06-22	1999-12-29	Elan Pharmaceuticals, Inc.	Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
EP1089977A1 (en)	1998-06-22	2001-04-11	Elan Pharmaceuticals, Inc.	Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
HRP990246A2 (en)	1998-08-07	2000-06-30	Du Pont Pharm Co	Succinoylamino benzodiazepines as inhibitors of a beta protein production
EP1313426A2 (en)	1998-12-24	2003-05-28	Bristol-Myers Squibb Pharma Company	Succinoylamino benzodiazepines as inhibitors of a-beta protein production
BR0014269A (en)*	1999-09-13	2002-07-02	Bristol Myers Squibb Pharma Co	Lactam compounds, their pharmaceutically acceptable salts and prodrugs, pharmaceutical composition, method of treating neurological disorders associated with the production of "beta" -amyloid, method of inhibiting "alpha" -secretase activity and uses of the compounds
AU2001257006A1 (en)	2000-04-11	2001-10-23	Du Pont Pharmaceuticals Company	Substituted lactams as inhibitors of abeta protein production
US6709054B2 (en)*	2002-01-22	2004-03-23	Prescient Partners, L.P.	Slipcover wrapping technique

2001
- 2001-04-11AUAU2001257006Apatent/AU2001257006A1/ennot_activeAbandoned
- 2001-04-11CACA002404273Apatent/CA2404273A1/ennot_activeAbandoned
- 2001-04-11JPJP2001575561Apatent/JP2004500419A/enactivePending
- 2001-04-11EPEP01930471Apatent/EP1289966A1/ennot_activeWithdrawn
- 2001-04-11USUS09/832,455patent/US6632812B2/ennot_activeExpired - Lifetime
- 2001-04-11WOPCT/US2001/011714patent/WO2001077086A1/ennot_activeApplication Discontinuation
2003
- 2003-10-14USUS10/685,031patent/US6900199B2/ennot_activeExpired - Lifetime
2004
- 2004-12-06USUS11/005,573patent/US7276495B2/ennot_activeExpired - Lifetime
2006
- 2006-02-06USUS11/348,091patent/US20060211679A1/ennot_activeAbandoned
2007
- 2007-01-19USUS11/655,637patent/US7390802B2/ennot_activeExpired - Lifetime
- 2007-04-19USUS11/788,708patent/US7498324B2/ennot_activeExpired - Fee Related
2009
- 2009-02-19USUS12/388,944patent/US7655647B2/ennot_activeExpired - Fee Related

Publication number	Publication date
US20080221087A1 (en)	2008-09-11
CA2404273A1 (en)	2001-10-18
US7390802B2 (en)	2008-06-24
US6632812B2 (en)	2003-10-14
US7276495B2 (en)	2007-10-02
US7498324B2 (en)	2009-03-03
WO2001077086A1 (en)	2001-10-18
US20070173491A1 (en)	2007-07-26
US20020025955A1 (en)	2002-02-28
US20090170831A1 (en)	2009-07-02
US6900199B2 (en)	2005-05-31
US20050234039A1 (en)	2005-10-20
EP1289966A1 (en)	2003-03-12
JP2004500419A (en)	2004-01-08
US20060211679A1 (en)	2006-09-21
US20040138201A1 (en)	2004-07-15
US7655647B2 (en)	2010-02-02

Publication	Publication Date	Title
AU2001257006A1 (en)	2001-10-23	Substituted lactams as inhibitors of abeta protein production
AU2001239791A1 (en)	2001-08-27	Succinoylamino carbocycles and heterocycles as inhibitors of abeta protein production
AU7997600A (en)	2001-04-23	Amino lactam sulfonamides as inhibitors of abeta protein production
IL151576A0 (en)	2003-04-10	Cyclic lactams as inhibitors of a-beta protein production
AU2003265235A1 (en)	2003-12-19	Non-affinity purification of proteins
IL147629A0 (en)	2002-08-14	LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
AU2002305205A1 (en)	2002-11-05	9-deazaguanine derivatives as inhibitors of gsk-3
GB0322515D0 (en)	2003-10-29	Enzymes for specific fragmentation of proteins
AU2001280201A1 (en)	2002-06-20	Methods of synthesizing cell-free protein
AU2002235189A1 (en)	2002-05-27	Production of 6-aminocaproic acid
AU2002367147A1 (en)	2003-07-15	Beta-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS
AU2001290075A1 (en)	2002-04-02	Novel alkanoic acid derivatives
AU2002330453A1 (en)	2003-06-05	Crystals of hydroxynorephedrine derivative
AU2001244692A1 (en)	2001-12-20	Novel crystal form of pyrrolidylthiocarbapenem derivative
AU2002214286A1 (en)	2002-05-27	Method of profiling protein
AU2001288092A1 (en)	2002-04-15	Method of crystallization
AU2001292307A1 (en)	2002-04-22	Non-deliquescent salt of 4-hydroxypiperidine derivative
AU2001249477A1 (en)	2001-10-08	Lactams as inhibitors of a-beta protein production
AU2001265935A1 (en)	2002-01-14	Production of biohydrolysates
AU2002210816A1 (en)	2002-05-15	Process for preparation of beta-phenethylamine derivative
GB2384779B (en)	2004-09-29	Method for the production of tagged proteins
AU2001284469A1 (en)	2002-03-22	Methods for crystallization of hydroxycarboxylic acids
AU2002234066A1 (en)	2002-05-15	Process for the production of amides
AU2002213477A1 (en)	2002-04-29	Process for preparation of n-substituted 2-sulfanylimidazoles
AU6907201A (en)	2001-12-24	Method for the production of caprolactam

Movatterモバイル変換

AU2001257006A1 - Substituted lactams as inhibitors of abeta protein production - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (3)

Publications (1)

Family

ID=22725848

Family Applications (1)

Country Status (6)

Families Citing this family (49)

Family Cites Families (92)

Also Published As

Similar Documents